Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease.
about
Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect?Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)Association of plasma des-acyl ghrelin levels with CKDAn adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis.Association of inflammatory cytokines with mortality in peritoneal dialysis patients.Kidney dysfunction in patients with pulmonary arterial hypertensionTunneled catheters with taurolidine-citrate-heparin lock solution significantly improve the inflammatory profile of hemodialysis patients.Evidence for anti-inflammatory effects of exercise in CKD.The bone-vascular axis in chronic kidney disease.Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney diseaseAn update on uremic toxins.Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT).Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)Evidence that p-cresol and IL-6 are adsorbed by the HFR cartridge: towards a new strategy to decrease systemic inflammation in dialyzed patients?Precedent fluctuation of serum hs-CRP to albumin ratios and mortality risk of clinically stable hemodialysis patients.Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney diseaseThe Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.Low resistin level is associated with poor hospitalization-free survival in hemodialysis patients.Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacyInterleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC StudyPathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.IL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients.Symmetric dimethylarginine as a proinflammatory agent in chronic kidney diseaseFibroblast growth factor 23 and Inflammation in CKDThe influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung diseaseCorrelation of Inflammation and Lipoprotein (a) with Hypercoagulability in Hemodialysis Patients.Interaction between acyl-ghrelin and BMI predicts clinical outcomes in hemodialysis patientsCardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study.Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure.Comparison analysis of nutritional scores for serial monitoring of nutritional status in hemodialysis patientsAccumulation of retained nonfunctional arteriovenous grafts correlates with severity of inflammation in asymptomatic ESRD patientsInflammatory factors and exercise in chronic kidney disease.Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease.Dual inhibiting senescence and epithelial-to-mesenchymal transition by erythropoietin preserve tubular epithelial cell regeneration and ameliorate renal fibrosis in unilateral ureteral obstruction.Association Between Anxiety and Depression With Dialysis Adequacy in Patients on Maintenance HemodialysisThe clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients.Chorioretinal thinning in chronic kidney disease links to inflammation and endothelial dysfunction.Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation.
P2860
Q28088361-9B7EF64D-27DD-4F2A-B3BC-F4DB911F1F3CQ28387350-53771729-5509-42EA-B665-52F7609D07DCQ30412038-5E7B34D5-6A23-4559-8AD8-47E1791DEF71Q33663437-68CCC197-D228-421E-B2C4-D7CD3D3EFD0AQ33712005-A63B69EE-C463-4753-A480-C4E98A874732Q33738621-E250576D-5E10-435B-B67D-350FCA95AE10Q33798334-BBDDA199-24E2-4E43-AEDD-8CD570518D4EQ34103416-FDD96844-9A13-46CF-B051-8D6940980622Q34402808-8ED28191-1F09-4363-AC1A-E47FBAEFFBC5Q34406428-AD7132A1-804D-4518-9002-96B0AE275941Q34641464-DB3F141E-E24F-4092-B79B-FB988197EE43Q34768530-3CFDEFC4-A3AE-4F74-8D4F-E7D30BBB70FCQ35051231-91F64815-43EF-4D15-AE99-5F63DF3388AEQ35141989-D70523E5-4F5C-40F6-97CF-FD44EA2A5509Q35154864-053F803E-0E91-4E69-8860-3F64B0D29862Q35202906-E0D97C9A-7C6C-4CF9-B5C9-6069F04B4C41Q35231318-5C5AA34B-F125-4EAA-9C33-676D23427398Q35646625-A800FE75-CF8B-47E2-8607-C0C0AFA6A213Q35680192-EF646CAF-480D-425B-BB94-269ADA0E44E8Q35859220-9D421E68-664E-4D78-9AEC-C2621E9A134EQ35891553-9B5F9ED7-F4A9-47D4-82F2-0AFD696361E6Q35913178-EC4464C4-E93C-4922-ACAA-93507AC710A5Q35915748-C8570B0D-450F-470B-BF2B-48DAE0E60604Q35983464-97FC9239-16B7-45D5-A028-8AE56EECCEF0Q35985806-C577EF41-A1A9-4F74-9937-FFBAE3E99F54Q36067879-B8029BD2-EF53-4F32-848F-A1D105D66EA5Q36158231-474B841E-7C3C-4FC1-908D-76695013A6DFQ36176347-F40601B9-67E1-4BE6-B346-C649B7F480AAQ36252993-8B1B744C-A1F4-42E0-8BB2-4B42234C9E6BQ36315383-6615065D-8D4D-45CF-93A1-C4209A8DBF13Q36389223-ED98684A-D91B-4108-8021-B4C1BC3DAC4BQ36652791-047C14D9-1365-4561-BB15-8F51848FF7CFQ36727560-E9949E94-F606-4745-BA25-47B5AD3067F6Q36882794-6590468F-FB2F-4ADB-AFE9-15538386619FQ37271191-BB6CE82B-B63A-4F70-B74E-11DF2EB2A965Q37367044-EEC2043A-CFB5-4E20-9C9D-8FDA51AC25EBQ37380375-10CC9E01-3F16-4D6D-B479-E61E98FBC148Q37391517-65167240-5DDD-48EA-83CA-3C525F7E1E20Q37469215-D4A27B3F-12E5-429E-89A3-C2A32ED0895DQ37583313-489CFF99-079D-4C5D-A0A3-70C2B1E5F961
P2860
Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Plasma interleukin-6 is indepe ...... s with chronic kidney disease.
@en
Plasma interleukin-6 is indepe ...... s with chronic kidney disease.
@nl
type
label
Plasma interleukin-6 is indepe ...... s with chronic kidney disease.
@en
Plasma interleukin-6 is indepe ...... s with chronic kidney disease.
@nl
prefLabel
Plasma interleukin-6 is indepe ...... s with chronic kidney disease.
@en
Plasma interleukin-6 is indepe ...... s with chronic kidney disease.
@nl
P2093
P921
P356
P1433
P1476
Plasma interleukin-6 is indepe ...... s with chronic kidney disease.
@en
P2093
Daniela V Barreto
European Uremic Toxin Work Group (EUTox)
Fellype C Barreto
Gabriel Choukroun
Horst-Dieter Lemke
Mohammed Temmar
Sophie Liabeuf
Ziad A Massy
P2888
P304
P356
10.1038/KI.2009.503
P407
P577
2009-12-16T00:00:00Z